- Volume 26 Issue 3
DOI QR Code
Analysis of Changes in Skin Dose During Weight Loss when Tomotherapyof Nasopharynx Cancer
비인두암 토모테라피 시 체중 감소에 따른 피부선량 변화 분석
- Received : 2016.05.12
- Accepted : 2016.06.02
- Published : 2016.06.30
For patients receiving chemotherapy and radiation therapy treatment progresses as vomiting, nausea, weight of the patient because of a loss of appetite it is reduced. The patient's weight and the distance from the skin and the treatment site is expected to be closer, thereby reducing the change in the skin because of this dose. This study tests using a loose see the difference between the volume change appears as the weight of the patient using the same phantom and the phantom body of the patient. To using the same as the position EBT film is attached to the skin of the treatment site and was adjusted to the thickness of the Bolus. And using a computerized treatment planning only tomotherapy equipment was passed under the conditions according to the thickness of the radiation dose. To baseline for accurate reproduction position using the MVCT was applied to treated with verification. By passing a total of three dose reduced the error, it was a measure of the film by using a dedicated scanner, EBT VIDAR scanner. Got an increase in the skin dose is displayed each time the thickness of the bolus reduced, in a bolus was completely removed with the highest value. If the changes appeared dose was greater weight loss patients to chemotherapy and therefore bolus thickness variation considering the weight loss of the patient when applying the tomotherapy of nasopharynx cancer was found that the increase in skin dose be increased. This large patient before treatment due to weight loss over the image verification is considered to be established should consider how to re-create your mask and treatment plan for fixing it.
radiation therapy;tomotherapy;nasopharynx cancer;gafchromic EBT3 film;skin dose
- Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2012, Ministry of Health and Welfare (2014).
- P. Jardel, J. Thariat, P. Blanchard, F. Elloumi, N. Toumi, R. J. Bensadoun, M. Frikha, J. Daoud, and J. Bourhis, Bulletin du Cancer. 5, 1 (2014).
- X. Wang, J. Lu, X. Xiong, G. Zhu, H. Ying, S. He, W. Hu, and C. Hu, Med. Dosim. 35, 151 (2010). https://doi.org/10.1016/j.meddos.2009.06.007
- S. A. Bhide, M. Davies, and K. Burke, Int. J. Radiat. Oncol. Biol. Phys. 76, 1360 (2010). https://doi.org/10.1016/j.ijrobp.2009.04.005
- D. I. Rosenthal, M. S. Chambers, C. D. Fuller, N. C. Rebueno, J. Garcia, and M. S. Kies, Int. J. Radia. Oncol. Biol. Phys. 72, 747 (2008). https://doi.org/10.1016/j.ijrobp.2008.01.012
- N. Lee, C. Chuang, J. M. Quivey, T. L. Phillips, P. Akazawa, and L. J. Verhey, Int. J. Radiat. Oncol. Biol. Phys. 53, 630 (2002). https://doi.org/10.1016/S0360-3016(02)02756-6
- M. J. Butson, T. Cheung, and P. K. Yu, Appl. Radiat. Isot. 64, 60 (2006). https://doi.org/10.1016/j.apradiso.2005.07.002
- K. Tournel, D. Verellen, M. Duchateau, Y. Fierens, N. Linthout, and T. Reynders, Radiother Oncol. 84, 34 (2007). https://doi.org/10.1016/j.radonc.2007.06.003